UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea’s share remains small in multinational pharmaceuticals’ operation
What is the proportion of the Korean market among multinational pharmaceuti...
by Marian Chu and Nam Doo-hyun
|
2017-05-09 02:53
라인
Can Jardiance threaten Forxiga's dominance in treating diabetes?
Korean regulators have officially recognized the effect of SGLT-2 (sodiumgl...
by Park Gi-taek
|
2017-05-04 13:30
라인
‘Korean drug market to grow twice faster than GDP until 2021’
Korea’s pharmaceutical market is likely to grow 4.4 percent on annual avera...
by Lee Hye-seon
|
2017-05-02 14:33
라인
FDA okays first drug for Batten disease
Biomarin Pharmaceutical won the go-ahead from the U.S. Food and Drug Admini...
by Constance Williams
|
2017-04-28 15:49
라인
JW Pharmaceutical worst of 10 major drugmakers for women to work in
In every election, presidential candidates have promised to shatter glass c...
by Nam Doo-hyun
|
2017-04-28 12:07
라인
FDA approves 1st treatment for liver cancer in decade
The U.S. Food and Drug Administration Thursday expanded the approved use of...
by Constance Williams
|
2017-04-28 11:25
라인
Boryung’s 1Q sales hit ₩99.8 billion
Boryung Pharmaceuticals보령제약 recorded sales of 99.8 billion won ($88.3 milli...
by Lee Hye-seon
|
2017-04-27 14:59
라인
How Daewoong released Korea’s 1st generic drug in US?
All eyes of Korean drugmakers are on Daewoong Pharmaceutical, as it has ach...
by Lee Hye-seon
|
2017-04-27 13:28
라인
Expectations rise about new bio drug going global
AFSTYLA, a hemophilia therapy developed by SK Chemicals SK케미칼이 jointly with...
by Lee Hye-seon
|
2017-04-26 18:06
라인
Customized subfertility therapy to debut in Korea
REKOVELLE (compound: follitropin delta), the personalized subfertility trea...
by Lee Hye-seon
|
2017-04-26 16:22
라인
FDA warns 14 firms against selling false cancer-curing products
The U.S. Food and Drug Administration (FDA) posted warning letters on Tuesd...
by Constance Williams
|
2017-04-26 10:49
라인
Samsung Bioepis wins first FDA approval for biosimilar drug
The U.S. Food and Drug Administration Friday approved Samsung Bioepis’ rheu...
by Marian Chu
|
2017-04-24 18:18
라인
Pharmacists oppose introduction of corporate-style drugstores
Koreans work hard. They are second-hardest working people among OECD nation...
by Constance Williams
|
2017-04-21 16:51
라인
Baxter allegedly forces workers to quit under disguise of advice
Baxter Korea, the Korean offshoot of the U.S.-based pharmaceutical company,...
by Marian Chu
|
2017-04-20 16:17
라인
Daewoong launches first generic antibiotic in US
Daewoong Pharmaceutical대웅제약 has launched its generic antibiotic “Meropenem”...
by Constance Williams
|
2017-04-19 18:03
라인
State auditors ‘fail to confirm Hanmi’s cover-up of clinical results’
The government’s top administrative watchdog has found Hanmi Pharmaceutical...
by Marian Chu
|
2017-04-18 15:23
라인
FDA stuns Eli-Lilly, Incyte by rejecting rheumatoid arthritis drug
Eli Lilly and Co. and Incyte Corp. said Friday that the U.S. Food and Drug ...
by Constance Williams
|
2017-04-17 17:17
라인
Cancer patients protest against Novartis Korea
Novartis Korea’s targeted anticancer treatment, Gleevec, is in danger of lo...
by Marian Chu
|
2017-04-17 15:04
라인
Korean firms stage ‘let’s-save-our drug’ drive
The “let’s-save-our drug” campaign -- initiated by the domestic medicine di...
by Lee Hye-seon
|
2017-04-14 15:30
라인
Hanmi preempts global incontinence drug market
Hanmi Pharma한미약품(CEOs Woo Jong-soo우종수 and Kwon Se-chang권세창) has grabbed ano...
by Lee Hye-seon
|
2017-04-12 18:37
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top